| |
| |
|
| Insider
Information: |
Goldsmith Bruce A |
| Relationship: |
CEO and President, Dir... |
| City: |
Westminster |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
15,983 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$23,495 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,983 |
|
|
| Total
Value |
$23,495 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -49.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allos Therapeutics Inc |
ALTH |
SVP, Corporate Develop... |
2012-09-04 |
0 |
|
0 |
Premium* |
|
|
Passage Bio, Inc. |
PASG |
CEO and President, Dir... |
2022-03-21 |
15,983 |
2020-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PASG |
Passage Bio, Inc. |
CEO and President |
• • – |
2022-03-21 |
4 |
B |
$3.15 |
$31,500 |
D/D |
10,000 |
15,983 |
2.81 |
% |
|
| PASG |
Passage Bio, Inc. |
CEO and President |
• • – |
2021-05-21 |
4 |
B |
$13.12 |
$26,230 |
D/D |
2,000 |
5,983 |
2.81 |
% |
|
| PASG |
Passage Bio, Inc. |
CEO and President |
• • – |
2020-03-03 |
4 |
B |
$18.00 |
$19,800 |
D/D |
1,100 |
1,100 |
2.81 |
% |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• • – |
2012-09-04 |
4 |
D |
$1.82 |
$631,418 |
D/D |
(346,933) |
0 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• – – |
2012-03-01 |
4 |
AS |
$1.50 |
$6,690 |
D/D |
(4,473) |
346,933 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• – – |
2012-02-29 |
4 |
AS |
$1.52 |
$6,869 |
D/D |
(4,505) |
351,406 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• – – |
2012-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
179,727 |
355,911 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• – – |
2012-02-24 |
4 |
AS |
$1.54 |
$888 |
D/D |
(575) |
176,184 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• – – |
2012-02-23 |
4 |
AS |
$1.58 |
$3,958 |
D/D |
(2,500) |
176,759 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• – – |
2011-11-16 |
4 |
AS |
$1.43 |
$430 |
D/D |
(300) |
179,259 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
SVP, Corporate Development |
• – – |
2011-11-15 |
4 |
AS |
$1.44 |
$18,008 |
D/D |
(12,465) |
179,559 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Corporate Development |
• – – |
2011-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
67,298 |
192,024 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Corporate Development |
• – – |
2011-02-24 |
4 |
AS |
$3.12 |
$1,583 |
D/D |
(507) |
124,726 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Corporate Development |
• – – |
2011-02-23 |
4 |
AS |
$3.25 |
$7,313 |
D/D |
(2,250) |
125,233 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Corporate Development |
• – – |
2010-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
100,671 |
127,483 |
0 |
- |
|
| ALTH |
Allos Therapeutics Inc |
VP, Corporate DevelopmentOffic |
• – – |
2010-08-27 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
26,812 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
